BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 15804180)

  • 1. Differential cytosolic delivery and presentation of antigen by listeriolysin O-liposomes to macrophages and dendritic cells.
    Stier EM; Mandal M; Lee KD
    Mol Pharm; 2005; 2(1):74-82. PubMed ID: 15804180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutants of listeriolysin O for enhanced liposomal delivery of macromolecules.
    Walls ZF; Goodell S; Andrews CD; Mathis J; Lee KD
    J Biotechnol; 2013 Apr; 164(4):500-2. PubMed ID: 23416330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen-loaded pH-sensitive hydrogel microparticles are taken up by dendritic cells with no requirement for targeting antibodies.
    Ruff LE; Mahmoud EA; Sankaranarayanan J; Morachis JM; Katayama CD; Corr M; Hedrick SM; Almutairi A
    Integr Biol (Camb); 2013 Jan; 5(1):195-203. PubMed ID: 23060228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choroidal dendritic cells require activation to present antigen and resident choroidal macrophages potentiate this response.
    Forrester JV; Lumsden L; Duncan L; Dick AD
    Br J Ophthalmol; 2005 Mar; 89(3):369-77. PubMed ID: 15722321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calreticulin P-domain-derived "Eat-me" peptides for enhancing liposomal uptake in dendritic cells.
    Mei KC; Thota N; Wei PS; Yi B; Bonacquisti EE; Nguyen J
    Int J Pharm; 2024 Mar; 653():123844. PubMed ID: 38272193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harnessing Microbial Effectors for Macrophage-Mediated Drug Delivery.
    Van Staden ADP; Visser JG; Powrie YSL; Smith C
    ACS Omega; 2024 Apr; 9(16):18260-18272. PubMed ID: 38680365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ribonuclease activity undermines immune sensing of naked extracellular RNA.
    Castellano M; Blanco V; Calzi ML; Costa B; Witwer K; Hill M; Cayota A; Segovia M; Tosar JP
    bioRxiv; 2024 Apr; ():. PubMed ID: 38712104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Listeriolysin O enhances cytoplasmic delivery by Her-2 targeting liposomes.
    Kullberg M; Owens JL; Mann K
    J Drug Target; 2010 May; 18(4):313-20. PubMed ID: 20201742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Listeriolysin generates a route for the presentation of exogenous antigens by major histocompatibility complex class I.
    Darji A; Chakraborty T; Wehland J; Weiss S
    Eur J Immunol; 1995 Oct; 25(10):2967-71. PubMed ID: 7589099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanotechnology for Enhanced Cytoplasmic and Organelle Delivery of Bioactive Molecules to Immune Cells.
    Li X; Omonova Tuychi Qizi C; Mohamed Khamis A; Zhang C; Su Z
    Pharm Res; 2022 Jun; 39(6):1065-1083. PubMed ID: 35661086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comparison Between Recombinant
    Teran-Navarro H; Salcines-Cuevas D; Calderon-Gonzalez R; Tobes R; Calvo-Montes J; Pérez-Del Molino Bernal IC; Yañez-Diaz S; Fresno M; Alvarez-Dominguez C
    Front Immunol; 2021; 12():632304. PubMed ID: 33953709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of RG1-VLP vaccine performance in BALB/c mice by substitution of alhydrogel with the next generation polyphosphazene adjuvant PCEP.
    Valencia SM; Zacharia A; Marin A; Matthews RL; Wu CK; Myers B; Sanders C; Difilippantonio S; Kirnbauer R; Roden RB; Pinto LA; Shoemaker RH; Andrianov AK; Marshall JD
    Hum Vaccin Immunother; 2021 Aug; 17(8):2748-2761. PubMed ID: 33573433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyphosphazene immunoadjuvants: Historical perspective and recent advances.
    Andrianov AK; Langer R
    J Control Release; 2021 Jan; 329():299-315. PubMed ID: 33285104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harnessing Macrophages for Controlled-Release Drug Delivery: Lessons From Microbes.
    Visser JG; Van Staden ADP; Smith C
    Front Pharmacol; 2019; 10():22. PubMed ID: 30740053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the safety and adjuvant effect of a detoxified listeriolysin O mutant on the humoral response to dengue virus antigens.
    Hernández-Flores KG; Calderón-Garcidueñas AL; Mellado-Sánchez G; Ruiz-Ramos R; Sánchez-Vargas LA; Thomas-Dupont P; Izaguirre-Hernández IY; Téllez-Sosa J; Martínez-Barnetche J; Wood L; Paterson Y; Cedillo-Barrón L; López-Franco O; Vivanco-Cid H
    Clin Exp Immunol; 2017 Apr; 188(1):109-126. PubMed ID: 27886660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-assembly of polyphosphazene immunoadjuvant with poly(ethylene oxide) enables advanced nanoscale delivery modalities and regulated pH-dependent cellular membrane activity.
    Andrianov AK; Marin A; Fuerst TR
    Heliyon; 2016 Apr; 2(4):e00102. PubMed ID: 27441274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Encapsulating immunostimulatory CpG oligonucleotides in listeriolysin O-liposomes promotes a Th1-type response and CTL activity.
    Andrews CD; Huh MS; Patton K; Higgins D; Van Nest G; Ott G; Lee KD
    Mol Pharm; 2012 May; 9(5):1118-25. PubMed ID: 22376145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conjugation of lipid and CpG-containing oligonucleotide yields an efficient method for liposome incorporation.
    Andrews CD; Provoda CJ; Ott G; Lee KD
    Bioconjug Chem; 2011 Jul; 22(7):1279-86. PubMed ID: 21612239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nondominant CD8 T cells are active players in the vaccine-induced antitumor immune response.
    Uram JN; Black CM; Flynn E; Huang L; Armstrong TD; Jaffee EM
    J Immunol; 2011 Apr; 186(7):3847-57. PubMed ID: 21346233
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.